This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

Highly Accessed Review

Practical aspects of treatment with drotrecogin alfa (activated)

Luigi Camporota and Duncan Wyncoll*

Critical Care 2007, 11(Suppl 5):S7 doi:10.1186/cc6158

No comments have yet been made on this article.

Post a comment